Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose hydrocortisone pulses for treatment-resistant depression
2006-006089-40Phase 4Terminated
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydrocortisone in treatment-resistant depression (TRD) and major depressive disorder (MDD) (3 arms), sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoint: Montgomery-Asberg Depression Rating Scale. Started Mar 2008; status: terminated.
02
Drugs
hydrocortisone
03
Conditions
treatment-resistant depression (TRD)major depressive disorder (MDD)
Beyond the preview
Go deeper on 2006-006089-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006089-40.